Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith McCrae

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 11, 2009
Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivoDmitri Simberg, Wan-Ming Zhang, Sergei Merkulov, et al.
ACS Nano|November 25, 2014
High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating propertiesGuankui Wang, Swetha Inturi, Natalie J Serkova, et al.
Circulation Research|May 11, 2023
A Post-Pandemic Enigma: The Cardiovascular Impact of Post-Acute Sequelae of SARS-CoV-2Tamanna K Singh, David A Zidar, Keith McCrae, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Promise of new vascular-disrupting agents balanced with cardiac toxicity: is it time for oncologists to get to know their cardiologists?Willem J van Heeckeren, Shyam Bhakta, Jose Ortiz, et al.
Biomaterials|April 28, 2009
Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearanceDmitri Simberg, Ji-Ho Park, Priya P Karmali, et al.
American Journal of Hematology|November 27, 2018
The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulationAlok A Khorana, Keith McCrae, Dejan Milentijevic, et al.
Journal of Neuro-Oncology|July 12, 2019
Phase II study of Dovitinib in recurrent glioblastomaMayur Sharma, Cathy Schilero, David M Peereboom, et al.
Targeted Oncology|August 20, 2022
Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint InhibitorsIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
Journal of Medical Economics|June 28, 2021
Healthcare costs of patients with cancer stratified by Khorana score risk levelsAlok A Khorana, Nicole M Kuderer, Keith McCrae, et al.
Cancer Medicine|September 21, 2020
Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levelsAlok A Khorana, Nicole M Kuderer, Keith McCrae, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 11, 2009
Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivoDmitri Simberg, Wan-Ming Zhang, Sergei Merkulov, et al.
ACS Nano|November 25, 2014
High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating propertiesGuankui Wang, Swetha Inturi, Natalie J Serkova, et al.
Circulation Research|May 11, 2023
A Post-Pandemic Enigma: The Cardiovascular Impact of Post-Acute Sequelae of SARS-CoV-2Tamanna K Singh, David A Zidar, Keith McCrae, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Promise of new vascular-disrupting agents balanced with cardiac toxicity: is it time for oncologists to get to know their cardiologists?Willem J van Heeckeren, Shyam Bhakta, Jose Ortiz, et al.
Biomaterials|April 28, 2009
Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearanceDmitri Simberg, Ji-Ho Park, Priya P Karmali, et al.
American Journal of Hematology|November 27, 2018
The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulationAlok A Khorana, Keith McCrae, Dejan Milentijevic, et al.
Journal of Neuro-Oncology|July 12, 2019
Phase II study of Dovitinib in recurrent glioblastomaMayur Sharma, Cathy Schilero, David M Peereboom, et al.
Targeted Oncology|August 20, 2022
Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint InhibitorsIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
Journal of Medical Economics|June 28, 2021
Healthcare costs of patients with cancer stratified by Khorana score risk levelsAlok A Khorana, Nicole M Kuderer, Keith McCrae, et al.
Cancer Medicine|September 21, 2020
Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levelsAlok A Khorana, Nicole M Kuderer, Keith McCrae, et al.
Pageof 4